Femring
Product Images NDC 72495-201

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Femring (NDC 72495-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Millicent Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Ndc 72495 201 05 Label)

This is a description of Femring®, a vaginal ring containing 12.4 mg estradiol acetate that delivers 0.05 mg estradiol per day for three months. It is intended for intravaginal use only and contains barium sulfate and cured elastomer as additional ingredients. It is manufactured by Millicent Pharma (NI) Limited and is a registered trademark of Millicent Pharma Limited. For reporting any suspected adverse reactions, users can contact Millicent or log on to the FDA website. The product is stored at controlled room temperature and comes with a tear here tab for full prescribing information.*

FDA Label Image

Label (Ndc 72495 202 10 Label)

This is a description of a medication called Femring® that comes in a vaginal ring form. It contains 24.8 mg of estradiol acetate, which delivers 0.10 mg of estradiol per day for three months. The other ingredients include barium sulfate and cured elastomer. It is manufactured by Millicent Pharma and is only intended for intravaginal use. Possible adverse reactions should be reported to Millicent or the FDA. It is a registered trademark of Millicent Pharma Limited. Storage must be at 25°C, with excursions permitted to 15°-30°C. Full prescribing information is provided.*

FDA Label Image

The Structural Formula Of Estradiol Acetate Is Chemically Described As Estra-1,3,5(10)-triene-3,17b-diol-3-acetate (Femring 01)

FDA Label Image

Figure 1. Mean Serum Estradiol Concentrations Following Multiple Dose Administration Of Femring (0.05 mg/day Estradiol) (second Dose Administered At 13 Weeks) (inset: Mean (±sd) Of Serum Concentrati (Femring 02)

This data shows the serum estradiol concentration (in pg/mL) over a period of 18 weeks, with measurements taken at week 1, 2, 5, 16, and 18. There are six measurements in total, all of which are the same value of 3888 pg/mL. The strange symbols/characters at the end are not readable and may have been introduced during the process.*

FDA Label Image

Step 3. Choose The Position That Is Most Comfortable For You. For Example, Lying Down Or Standing With 1 Leg Up (see Figures A And B). (Femring 03)

FDA Label Image

Use Your Thumb And Index Finger (pointer Finger) To Press The Sides Of The Ring Together. You May Find It Easier To Insert Femring If You Twist It Into A Figure-eight Shape (see Figure C). (Femring 04)

FDA Label Image

Use Your Other Hand And Hold Open The Folds Of Skin Around Your Vagina (see Figure D). (Femring 05)

FDA Label Image

Place The Tip Of The Ring In The Vaginal Opening. Use Your Index Finger To Push The Folded Ring Gently Into Your Vagina. Push It Up Towards Your Lower Back As Far As You Can (see Figure E). (Femring 06)

FDA Label Image

If The Ring Feels Uncomfortable, You May Not Have Pushed The Ring Into Your Vagina Far Enough. Use Your Index Finger To Push The Ring As Far As You Can Into Your Vagina (see Figure F). (Femring 07)

FDA Label Image

Femring Should Now Be In Your Upper Vagina (see Figure G). The Exact Position Of Femring In The Vagina Is Not Important For It To Work. (Femring 08)

FDA Label Image

Put A Finger Into Your Vagina And Hook It Through The Ring (see Figure H (Femring 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.